Einstein Experts for Media

Search Results

Nir Barzilai, M.D.

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

AgingBiology of agingLongevity genes

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, includingTheNew York Times, PBS’ “NOVA scienceNow” and National Geographic.read more...

Jill P. Crandall, M.D.

Professor, Medicine (Endocrinology), Einstein

Director, Diabetes Clinical Trials Unit, Einstein

Attending Physician, Endocrinology, Montefiore Health System

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes.read more...

Mario J. Garcia, M.D.

Co-Director, Montefiore Einstein Center for Heart and Vascular Care

Chief, Cardiology, Department of Medicine, Einstein and Montefiore Health System

Professor, Medicine (Cardiology), Einstein

Pauline A. Levitt Chair in Medicine, Einstein

Heart DiseaseCardiologyCardiac imaging

Cardiovascular disease

An expert in diabetes prevention, Dr. Crandall is a principal investigator in the NIH-funded Diabetes Prevention Program Outcomes Study, which showed that sustaining weight loss or taking an anti-diabetic drug can stave off type 2 diabetes in people at high risk for the disease. The American Diabetes Association recently funded Dr. Crandall to study whether the wine ingredient resveratrol can prevent diabetes in patients with prediabetes.read more...

John M. Greally, Ph.D., M.B.,B.Ch.

Dr. Greally began his career as a pediatrician who subspecialized in clinical genetics, seeing patients with genetic syndromes, birth defects and developmental problems. Now, Dr. Greally seeks to understand how genetic disease is caused not by DNA mutations, but due to abnormalities in how genes are switched off and on – a field known as epigenomics. read more...

Meredith A. Hawkins, M.D.

Professor, Medicine (Endocrinology), Einstein

Director, Global Diabetes Institute, Einstein

Attending Physician, Medicine, Montefiore Health System

Harold and Muriel Block Chair in Medicine, Einstein

DiabetesGlobal diabetesType 2 diabetes

Malnutrition diabetesGlobal health

Dr. Hawkins specializes in diabetes, with a particular emphasis on the dramatic rise of the disease worldwide. She has traveled the globe investigating diabetes since 1996 and is the founding director of the Global Diabetes Institute (GDI) at Einstein, which conducts diabetes education and training for healthcare workers in South and Central America, Eastern Europe, Africa and Asia.read more...

Dr. Pessin directs the Einstein-Mount Sinai Diabetes Research Center, one of only sixteen NIH-funded diabetes centers of its kind in the country. He guides the research of more than 90 scientists investigating type 1 (formerly juvenile) and type 2 (formerly adult-onset) diabetes. The center also includes training programs and community-based activities in the Bronx. Dr. Pessin’s own research focuses on insulin signaling and the mechanisms contributing to the onset of type 1 diabetes.read more...

Gary J. Schwartz, Ph.D.

Professor, Medicine (Endocrinology)

Professor, Dominick P. Purpura Department of Neuroscience

Neurobiology of obesity and diabetesGastric-bypass surgery

Dr. Schwartz studies how the gut and the brain act together to determine how much people eat. He has identified sites in the gastrointestinal tract and brain that detect nutrients and has discovered how these regions are linked to food intake, obesity and diabetes. He also studies gastric-bypass surgery and the key neural and hormonal mechanisms responsible for the significant and long-lasting improvements in body weight, food intake and diabetes following the procedure.read more...

Harry Shamoon, M.D.

Associate Dean, Clinical and Translational Research, Einstein

Director, Block Institute for Clinical and Translational Research at Einstein and Montefiore Health System

Professor, Medicine (Endocrinology), Einstein

Attending Physician, Medicine, Montefiore Health System

Translational researchClinical researchDiabetes

Dr. Shamoon represents Einstein and Montefiore in the NIH’s Clinical and Translational Science Award Consortium, an elite group of 60 medical research institutions working to improve health outcomes by facilitating the translation of scientific discoveries into medical practice. Dr. Shamoon’s research focus is diabetes, and he has directed two landmark NIH studies, the Diabetes Control and Complications Trial and the Diabetes Prevention Program.read more...

Dr. Surks is a thyroid disease expert with 40 years of experience in basic and clinical research, education and patient care. In addition to thyroid disorders, his clinical practice focuses on conditions of the pituitary, parathyroid and adrenal glands and on metabolic bone disease. His recent research has involved subclinical thyroid diseases and determining a reference range for TSH (thyroid-stimulating hormone) levels in people. read more...

Dr. Walker is a nurse scientist, diabetes nurse specialist and certified diabetes educator who specializes in studying how to help people with diabetes better manage their disease by adhering to their medication regimen, eating a healthy diet, exercising, and getting regular screening for complications. She is recognized for leading large NIH-funded behavioral intervention studies in minority diabetes populations—and has a program of research studies showing that regular phone calls to people with diabetes can be successful in helping them self-manage their disease and improve their diabetes control. read more...

Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor. She is associate editor of the journal Diabetes Careand author ofThe Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements.read more...

Joel Zonszein, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Clinical Diabetes Center, Montefiore Health System

Diabetes (clinical)Type 1 diabetesType 2 diabetes

Diabetes preventionCardiovascular disease

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial and the Diabetes Prevention Program. He has a special interest in understanding cardiovascular disease in people with diabetes and serves as the principal investigator of an ongoing NIH-sponsored study to find the best way to manage coronary artery disease in patients with type 2 diabetes. read more...